NCT00614536View on ClinicalTrials.gov

Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period

CompletedOBSERVATIONAL

Enrollment

1,142

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Gastroesophageal RefluxPharyngeal Diseases

Interventions

DRUG

Rabeprazole Sodium

10mg - 20mg tablet once or twice daily for 12weeks

All Listed Sponsors

lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT00614536 - Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period | Biotech Hunter | Biotech Hunter